| The N-ras oncogene assigned to the short arm of human chromosome 1. | None |
| Localisation of the human N-ras oncogene to chromosome 1cen - p21 by in situ hybridisation. | None |
| The effects of N-ras oncogene expression on PDGF-BB stimulated responses in cultured mouse myoblasts. | None |
| Introduction of an activated N-ras oncogene alters the growth characteristics of the interleukin 6-dependent myeloma cell line ANBL6. | None |
| The mutation of N-ras oncogene does not involve myeloid and erythroid lineages in a case of multiple myeloma. | None |
| Dynamics of active lamellae in cultured epithelial cells: effects of expression of exogenous N-ras oncogene. | None |
| N-ras oncogene causes AP-2 transcriptional self-interference, which leads to transformation. | None |
| Identification of multiple promoters within the N-ras proto-oncogene. | None |
| An overexpressed N-ras proto-oncogene cooperates with N-methylnitrosourea in mouse mammary carcinogenesis. | None |
| Persistence of an activating N-RAS oncogene mutation in clonogenic progenitor cells from an acute myeloid leukaemia patient in remission. | None |
| Activated N-ras oncogene and N-ras proto-oncogene act through the same pathway for in vivo tumorigenesis. | None |
| Site-specific modification of the human N-ras proto-oncogene with each diol epoxide metabolite of benzo[a]pyrene and thermal denaturation studies of the adducted duplexes. | None |
| Cloning, sequencing, and embryonic expression of an N-ras proto-oncogene isolated from an enriched zebrafish (Danio rerio) cDNA library. | None |
| Effects of melatonin on mammary gland lesions in transgenic mice overexpressing N-ras proto-oncogene. | None |